| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8669200 | The Journal of Heart and Lung Transplantation | 2018 | 15 Pages |
Abstract
The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
James K. MD, Rongbing DrPH, MPH, Jennifer Cowger, Theo M.M.H. MBA, Takeshi MD, PhD, Stephan MD, PhD, FRCS, Rhiannon MSc, MMath, Jenny PhD, Paul MD, Jan MD, Daniel MD, Kadir MD, PhD, Margaret M. MD,